Newstral
Article
bizjournals.com on 2017-11-08 16:53
GlaxoSmithKline R&D leader departing for UK government job
Related news
- U.S. government will buy more of GlaxoSmithKline and Vir's COVID antibody drug1 min readwsj.com
- While cutting jobs in Pa., GlaxoSmithKline will open global R&D center in Md.bizjournals.com
- FAstraZeneca pours millions into China R&Dft.com
- Glaxo moving Philly R&D jobs southPhilly.com
- Millions rorted from government R&D schemetheage.com.au
- Government announces £32m in R&D fund...expressandstar.com
- Third Circuit Extends Actavis to Reverse Settlement Agreements Involving Non-Cash Consideration - King Drug Company of Florence, Inc. v. Smithkline Beecham Corp. d/b/a GlaxoSmithKlinejdsupra.com
- ADrugmaker GSK reviewing its R&D programs under new CEOapnewsarchive.com
- GSK chooses Maryland for new vaccine R&D centerbizjournals.com
- NIC CEO: 'We are the R&D shop for government'bizjournals.com
- U.S. Government Urged to Boost Technology R&Dwsj.com
- FGlaxoSmithKline: Out of stepft.com
- GlaxoSmithKline Names CEOwsj.com
- 3D & R3.22.146.74
- GlaxoSmithKline posts loss blending businessesThe Salt Lake Tribune
- GlaxoSmithKline profits rise 34 percentdothaneagle.com
- GlaxoSmithKline acquiring Tesaro for $5.1Bbizjournals.com
- GlaxoSmithKline to close Moon operationspost-gazette.com
- TGlaxoSmithKline receives boost in Chinathisismoney.co.uk